NFKB1 and cancer: The known main mechanisms of platin resistance reported to date include cancer stem cells (CSCs) [50], epithelial-to-mesenchymal transition (EMT) [51], abnormal DNA repair-related pathways [52], and the NF-κB and PI3K/AKT/mTOR signaling pathways [53].